Brief: IGM Biosciences, Atreca, Beigene To Collaborate To Help Address Covid-19

Atreca

29/04/2020 22:26

April 29 (Reuters) - Beigene Ltd  6160.HK :
    * IGM BIOSCIENCES INC - ATRECA, INC. BEIGENE, LTD. AND IGM
BIOSCIENCES, INC. ANNOUNCED THEIR PLANS TO COLLABORATE TO HELP
ADDRESS COVID-19 PANDEMIC
    * IGM BIOSCIENCES - ATRECA, BEIGENE, CO TO DISCOVER,
DEVELOP,
MANUFACTURE NOVEL IGM, IGA ANTIBODIES TARGETING SARS-COV-2 FOR
POTENTIAL TREATMENT OF COVID-19
    * IGM BIOSCIENCES INC - PARTIES HAVE AGREED TO BEGIN WORK
IMMEDIATELY AND PLAN TO FINALIZE FINANCIAL DETAILS AND OTHER
TERMS IN FUTURE
    * IGM BIOSCIENCES - ATRECA, IGM HAVE ENTERED TRANSFER AND
COLLABORATION AGREEMENT TO ENABLE PARTIES TO BEGIN WORKING
TOGETHER IMMEDIATELY
    * IGM BIOSCIENCES INC - ATRECA, IGM, AND BEIGENE PLAN TO
DISCUSS
FURTHER TERMS AND ARRANGEMENTS IN FUTURE
    * IGM BIOSCIENCES - IF RESEARCH, MANUFACTURING, REGULATORY
ACTIVITIES PROCEED VERY WELL, COS BELIEVE ANTIBODY MAY BE READY
TO BEGIN TESTING IN H1 2021

Source text for Eikon:  ID:nGNX4rL1cd 
Further company coverage:  6160.HK 

 ((Reuters.Briefs@thomsonreuters.com;))